FAB1844A

antibody from R&D Systems

Targeting: KIR2DL1 47.11, CD158A, cl-42, nkat1, p58.1

Flow cytometry (Recommended by provider)

Antibody Data

Product number

FAB1844A

Provider

R&D Systems

Product name

Anti-Human KIR2DL1/CD158a APC-conjugated Monoclonal Antibody (Clone 143211)

Antibody type

Monoclonal

Antigen

BaF3 mouse pro-B cell line transfected with human KIR2DL1/CD158a

Description

Protein A or G purified from hybridoma culture supernatant

Reactivity

Human

Host

Mouse

Antigen sequence

P43626


Isotype

IgG

Vial size

100 Tests

References

Submitted references

NK Cell Responses to Human Tick-Borne Encephalitis Virus Infection.

Blom K, Braun M, Pakalniene J, Lunemann S, Enqvist M, Dailidyte L, Schaffer M, Lindquist L, Mickiene A, Michaëlsson J, Ljunggren HG, Gredmark-Russ S
Journal of immunology (Baltimore, Md. : 1950) 2016 Oct 1;197(7):2762-71

---

Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cells.

Marquardt N, Béziat V, Nyström S, Hengst J, Ivarsson MA, Kekäläinen E, Johansson H, Mjösberg J, Westgren M, Lankisch TO, Wedemeyer H, Ellis EC, Ljunggren HG, Michaëlsson J, Björkström NK
Journal of immunology (Baltimore, Md. : 1950) 2015 Mar 15;194(6):2467-71

---

Tracking in vivo dynamics of NK cells transferred in patients undergoing stem cell transplantation.

Killig M, Friedrichs B, Meisig J, Gentilini C, Blüthgen N, Loddenkemper C, Labopin M, Basara N, Pfrepper C, Niederwieser DW, Uharek L, Romagnani C
European journal of immunology 2014 Sep;44(9):2822-34

---

Modulation of the natural killer cell KIR repertoire by cytomegalovirus infection.

Charoudeh HN, Terszowski G, Czaja K, Gonzalez A, Schmitter K, Stern M
European journal of immunology 2013 Feb;43(2):480-7

---

CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients.

Béziat V, Dalgard O, Asselah T, Halfon P, Bedossa P, Boudifa A, Hervier B, Theodorou I, Martinot M, Debré P, Björkström NK, Malmberg KJ, Marcellin P, Vieillard V
European journal of immunology 2012 Feb;42(2):447-57

---

NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs.

Béziat V, Descours B, Parizot C, Debré P, Vieillard V
PloS one 2010 Aug 6;5(8):e11966

---

Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components.

Alici E, Sutlu T, Björkstrand B, Gilljam M, Stellan B, Nahi H, Quezada HC, Gahrton G, Ljunggren HG, Dilber MS
Blood 2008 Mar 15;111(6):3155-62